Tweedy Browne's Strategic Moves: Significant Reduction in FMC Corp
Tweedy Browne (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, providing insights into its investment moves during this period. The firm is managed by its Management Committee, which includes Jay Hill, Thomas H. Shrager, John D. Spears, and Robert Q. Wyckoff, Jr., with tenures ranging from 18 to 47 years. Tweedy Browne (Trades, Portfolio) is owned by its Managing Directors and certain other employees, alongside a majority interest held by Affiliated Managers Group, Inc. (AMG). AMG ensures operational autonomy and facilitates ownership transfer and succession. Historically, Benjamin Graham, through Graham-Newman Corp., was a primary brokerage client. The Tweedy Browne (Trades, Portfolio) Value Fund focuses on long-term capital growth by investing in undervalued U.S. and foreign equity securities, primarily in developed markets, while hedging foreign currency exposure back into the U.S. dollar where feasible.
Tweedy Browne (Trades, Portfolio) added a total of 16 stocks, with notable additions including:
The most significant addition was HCI Group Inc (NYSE:HCI), with 1,981 shares, accounting for 0.03% of the portfolio and a total value of $295,630.
The second largest addition was Alliance Resource Partners LP (NASDAQ:ARLP), consisting of 8,755 shares, representing approximately 0.02% of the portfolio, with a total value of $238,840.
The third largest addition was Blue Owl Capital Corp (NYSE:OBDC), with 13,431 shares, accounting for 0.02% of the portfolio and a total value of $196,900.
Tweedy Browne (Trades, Portfolio) also reduced positions in 41 stocks. The most significant changes include:
Reduced FMC Corp (NYSE:FMC) by 2,574,837 shares, resulting in an -89.96% decrease in shares and an -8.44% impact on the portfolio. The stock traded at an average price of $44.42 during the quarter and has returned 3.61% over the past 3 months and -21.95% year-to-date.
Reduced Johnson & Johnson (NYSE:JNJ) by 642,200 shares, resulting in a -59.44% reduction in shares and a -6.26% impact on the portfolio. The stock traded at an average price of $156.47 during the quarter and has returned -4.25% over the past 3 months and 3.39% year-to-date.
At the first quarter of 2025, Tweedy Browne (Trades, Portfolio)'s portfolio included 59 stocks. The top holdings were 14.51% in CNH Industrial NV (NYSE:CNH), 11.82% in Berkshire Hathaway Inc (NYSE:BRK.A), 10.4% in Coca-Cola Femsa SAB de CV (NYSE:KOF), 9.22% in Alphabet Inc (NASDAQ:GOOGL), and 7.98% in Ionis Pharmaceuticals Inc (NASDAQ:IONS).
The holdings are mainly concentrated in 9 of the 11 industries: Financial Services, Industrials, Healthcare, Consumer Defensive, Communication Services, Consumer Cyclical, Energy, Basic Materials, and Technology.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
22 minutes ago
- Business Insider
Why Is VSee Health Stock Down 55% Today?
VSee Health (VSEE) stock plummeted on Monday after the telehealth company received a notice from The Nasdaq Stock Market LLC's (NDAQ) Listing Qualifications Department. The company is not in compliance with Nasdaq listing rules, including failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024. It has also failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The Listing Qualifications Department has denied VSee Health's request for continued listing. While the company intends to appeal this decision, it expects shares to be delisted from the exchange when markets open on Thursday. When this happens, the company intends for its shares to be listed on OTC Markets (OTCM). VSee Health stock was down 53.79% in pre-market trading on Monday, following a 3.65% dip on Friday. This extended the company's 2.94% drop year-to-date and 38.6% fall over the past 12 months. Is VSee Health Stock a Buy, Sell, or Hold? Turning to Wall Street, analyst coverage of VSee Health is lacking. Luckily, TipRanks' AI analyst Spark has it covered. Spark rates VSEE stock a Neutral (46) with no price target. It cites 'strong revenue growth and recent strategic contracts' as reasons for this stance.
Business Insider
an hour ago
- Business Insider
Morgan Stanley Weighs In on Tesla Stock as Musk Reallocates Resources
Tesla (NASDAQ:TSLA) has long considered itself much more than an EV maker, but might it have bitten off more than it can chew? Signs are pointing that way, with the company now appearing to scale back at least one of its ambitious initiatives. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. That initiative is Dojo – Tesla's in-house supercomputer program designed to process the massive volumes of data and video collected from its vehicles to train AI models for the FSD (full self-driving) system and the Optimus robot. Last Thursday, Bloomberg News reported that Tesla is shutting down the program, with team leader Peter Bannon set to depart, according to sources familiar with the matter. The report claims CEO Elon Musk made the call as Tesla leans more heavily on external partners like Nvidia and AMD for computing power, and Samsung Electronics for chip production. About 20 Dojo engineers have reportedly left for the startup DensityAI, while the remainder will be reassigned to other computing projects. For Morgan Stanley analyst Adam Jonas, the news raises important strategic and financial implications. He sees the move as potentially part of a broader efficiency drive, aimed at trimming costs from a project that likely carried substantial capital and operating expenses. Tesla's Q2 results already flagged higher opex tied to AI initiatives, expanded training capacity at its Texas Gigafactory, and an FY25 capex forecast north of $9 billion – much of it earmarked for AI-related investments. One possible beneficiary of this pivot is Musk's privately held xAI. Jonas notes that xAI has been handling a growing share of Tesla's AI 'brain' development, leveraging both social media data from X and real-world driving data from Tesla vehicles. Scaling back or eliminating Dojo could strengthen the case for tighter collaboration between the two entities. Jonas also sees a potential shift in Tesla's focus toward robotics and edge inference capabilities. Musk has often pointed to the 'latent strategic potential' of Tesla's global vehicle fleet as a distributed inference network. With Optimus moving closer to commercialization, Jonas thinks Tesla may redirect incremental capex and R&D toward driving down robot production costs and improving manufacturability – whether for robotaxis or humanoid robots. And timing may be on Tesla's side. The once-severe GPU shortage that Musk often cited has eased considerably, removing one of the key constraints that had made in-house compute resources like Dojo more urgent in the past. For now, Jonas is holding firm on his Overweight (i.e., Buy) rating for TSLA stock, keeping a $410 price target that points to ~21% upside. (To watch Jonas' track record, click here) That bullish stance stands in contrast to the broader Street, where TSLA carries 15 Holds, 14 Buys, and 8 Sells, for a Hold (i.e., Neutral) consensus overall. With shares trading at $339.03, the average price target of $307.23 points to a potential 9% pullback over the next year. (See TSLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Insider
an hour ago
- Business Insider
Raymond James Keeps Their Buy Rating on EPR Properties (EPR)
Raymond James analyst RJ Milligan maintained a Buy rating on EPR Properties today and set a price target of $62.00. The company's shares closed today at $52.81. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Milligan is a 4-star analyst with an average return of 7.5% and a 57.93% success rate. Milligan covers the Real Estate sector, focusing on stocks such as CTO Realty Growth, Kite Realty Group, and EPR Properties. In addition to Raymond James, EPR Properties also received a Buy from Stifel Nicolaus's Simon Yarmak in a report issued on July 31. However, on August 8, Truist Financial maintained a Hold rating on EPR Properties (NYSE: EPR). Based on EPR Properties' latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $165.85 million and a net profit of $75.64 million. In comparison, last year the company earned a revenue of $158.68 million and had a net profit of $45.1 million Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EPR in relation to earlier this year. Most recently, in June 2025, Robin Peppe Sterneck, a Director at EPR sold 3,796.00 shares for a total of $215,347.08.
